期刊文献+

不同黄体支持方法对体外受精-胚胎移植结果的影响 被引量:6

Effect of different luteal support methods on the outcome of in vitro fertilization-embryo transfer
下载PDF
导出
摘要 目的研究不同黄体支持方法对体外受精-胚胎移植(IVF-ET)结果的影响,并探讨促性腺激素释放激素类似物(GnRH-a)在黄体支持中的临床效果。方法回顾性分析352个IVF/ICSI-ET周期的资料,其中单用黄体酮125例(A组),口服联合阴道用孕酮107例(B组),在B组基础上于取卵后6天加用一次注射用醋酸曲普瑞林0.1 mg皮下注射120例(C组),比较三组IVF-ET的结果。结果 A组与B组间临床妊娠率、种植率以及验孕日孕酮(P)和促绒毛膜性腺激素(HCG)水平差异无统计学意义(P>0.017);C组的生化妊娠率、临床妊娠率、种植率以及验孕日P和HCG水平显著高于A组和B组,差异有统计学意义(P<0.017);三组间宫外孕、流产率、卵巢过度刺激综合征(OHSS)发生率差异无统计学意义(P>0.05)。结论口服联合阴道用孕酮法的临床效果等同于肌肉注射黄体酮法,但前者使用方便,患者较易接受。而GnRH-a在黄体支持中的新应用显示了其较好的临床效果。 Objective To investigate the effect of different luteal support methods on outcome of in vitro fertilization -embryo transfer and explore the clinical effect of GnRH-αin luteal support treatment .Methods Clinical data of 352 IVF/ICSI-ET cycles were retrospectively analyzed .They were divided into group A ,B and C according to different luteal support treatments .In the group A ( n =125),progesterone injection alone was used as luteal support .In the group B (n =107),oral plus vaginal progesterone were used as luteal support.In the group C (n =120),oral plus vaginal progesterone and GnRH-a were used as luteal support.In the group C,a sub-cutaneous injection of 0.1 mg Diphereline was also performed on the 6th days after abstracting oocyte .The outcome of IVF/ICSI was compared among the three groups .Results There was no statistical difference between the group A and group B in the clinical preg -nancy rate,implantation rate and levels of progesterone and HCG on the day for testing gestation (P〉0.017).However,all the indexes in the group C were significant higher than that in the group A and B ( P〈0.017 ) .There are no statistical differences among the three groups in ectopic pregnancy rates ,abortion rates and ovarian hyperstimulation syndrome rates .Conclusion The clinical effect of oral plus vaginal progesterone is equal to that of progesterone injection .However,oral plus vaginal progesterone method is more convenient in application and easier to be accepted by patients .In addition,GnRH-αcan improve the treatment outcomes .
出处 《实用医院临床杂志》 2014年第5期57-60,共4页 Practical Journal of Clinical Medicine
关键词 促性腺激素释放激素类似物 黄体酮 地屈孕酮 黄体酮阴道缓释凝胶 辅助生殖 体外受精-胚胎移植 黄体 支持 Gonadotropin releasing hormone analogues Progesterone injection Dydrogesterone tablets Progesterone sustained release vaginal gel Assisted reproductive technology In vitro fertilization-embryo transfer Luteal support
  • 相关文献

参考文献11

  • 1Edwards RG. Physilologieal and molecular aspects of human implan- tation [ J ]. Hum Reprod, 1995,10 ( suppl 2) : 1-13.
  • 2柳雪琴,黄卡立,李艳梅.地屈孕酮在体外受精中黄体支持作用的效果分析[J].广西医学,2010,32(10):1183-1185. 被引量:4
  • 3Elena Y, Shelley H, Loasise G, et al. Crinone vaginal gel is equally effective and better tolerated than intramnscular progesterone for lute- al phase support in in vitro fertilization-embryo transfer cycles:a pro- spective randomized study [ J ]. Fertil Steril, 2010,94 ( 7 ) : 2596- 2599.
  • 4Zarutskie PW, Phillips JA. A meta-analysis of the route of administra- tion of luteal phase support in assisted reproductive technology : vagi- nal versus intramuscular progesterone [ J ]. Fertil Steril, 2009,92 (1) :163-169.
  • 5Manno M, Marchesan E, Cicutto D, et al. Grearer implantation and pregnancy rates with vaginal progesterone in intraeytoplasmic sperm injection but not in in vitro fertilization cycles:a retrospective studyE J ]- Fertil Steri1,2005,83 ( 5 ) : 1391-1396.
  • 6龚斐,蔡素芬,卢光琇.两种阴道给药黄体支持药物在IVF-ET/ICSI后用药的比较研究[J].实用妇产科杂志,2012,28(3):199-201. 被引量:21
  • 7Jan T, Andr H, Raquelmc C, et al. Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist-and antagonist-treated ovarian stimulation cycles [ J]. Hum Reprod,2006,21 (10) :2572-2579.
  • 8Tesarik J, Hazout A, Mendoza C. Enhancement of embryo develop- mental potential by a single administration of GnRH agonist at the time of implantation [ J ]. Human Reproduction, 2004, 19 : 1176- 1180.
  • 9Esarik J, Hazout A, Mendoza-Tesarik R, et al. Beneficial effect of lu- teal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist-and antagonist treated ovarian stimulation cycles[ J]. Human Reproduction,2006,21:2572-2579.
  • 10Pirard C, Donnez J, Loumaye E. GnRH agonist as novel luteal sup- port:results of a randomized, parallel group, feasibility study using intranasal administration of buserelin [ J ]. Human Reproduction, 2005,20 : 1798-1804.

二级参考文献12

  • 1Penzias AS.Luteal phase support.Fertil Steril[J].2002,77(2):318-323.
  • 2Pritts EA,Atwood AK.Luteal phase support in infertility treatment:a meta-analysis of the randomized trials[J].Hum Reprod,2002,17(9):2 287-2 299.
  • 3Tavaniotou A,Smitz J,Bourgain C,et al.Comparison between different routes of progesterone administration as luteal phase support in infertility treatments[J].Hum Rep rod Update,2000,6(2):139-148.
  • 4Penzias AS,Alper MM.Luteal support with vaginal micronized progesterone gel in assisted reproduction[J].Reprod Biomed Online,2003,6(3):287-295.
  • 5Cicinelli E,Ziegler D,Bulletti C,et al.Direct transport of progesterone from vagina to uterus[J].Obstetrics and Gynecology,2000,95(3):403-406.
  • 6Schindler AE,Campagnoli C,Druckmann R,et al.Classification and pharmacology of progestins[J].Maturitas,2003,46(suppl 1):7-16.
  • 7Fatemi HM, Popovie-Todorovic B, Papanikolaou E, et al. An update of luteal phase support in stimulated IVF cycles [ J ]. Hum Reprod Update, 2007,13 (6) :581 - 590.
  • 8Elena Yanushpolsky MD, Shelley Hurwitz PhD, Loasise Greenberg MEd, et al. Crinone vaginal gel is equally effective and better tolera- ted than intramuscular progesterone for luteal phase support in in vitro fertilization-embryo transfer cycles: a prospective randomized study [ J ]. Fertility and Sterility, 2010,94 ( 7 ) : 2596 - 2599.
  • 9Levy T, Yairi Y, Bar Hava I. Pharmacokinetics of the progesterone containing vaginal tablet and its use in assisted reproduction [ J ]. Steroids, 2000, 65 ( 10 - 11 ) : 645 - 649.
  • 10Fanchin R, Righini C, Olivennes F, et al. Uterine contractions at the time of embryo transfer alter pregnancy rates after in vitro fertilization [J]. Hum Reprod, 1998,13(7) :1968 -1974.

共引文献23

同被引文献41

  • 1陆小激,冯云,张爱军,孙贻娟.以胚胎质量评分预测体外受精-胚胎移植妊娠结局[J].上海医学,2006,29(3):169-172. 被引量:18
  • 2Corbett S, Shmorgun D, Claman P, et al. The prevention of ovarian hyperstimulation syndrome. [J]. Obstet Gynaecol Can, 2014, 36 ( 11 ) :1024-1036.
  • 3Nouri K, Haslinger P, Szabo L, et al. Polymorphisms of VEGF and VEGF receptors are associated with the occurrence of ovarian hypers- timulation syndrome (OHSS) -a retrospective case-control study[J] J Ovarian Res ,2014,7:54.
  • 4Corbett S, Shmorgun D, Claman P, et al. The prevention of ovarian & hyperstimulation syndrome [J]. J Obstet Gynaecol Can, 2014,36 (11) :1024-36.
  • 5Ozgun MT, Batukan C, Oner G. Removal of ascites up to 7.5 liters on one occasion and 45 liters in total may be safe in patients With hyerstimulation syndrome [J]. Gynecal Endocrinol, 2008,24( 11 ) :656-658.
  • 6Haas J, Baum M, Meridor K, et al. Is severe OHSS associated with adverse pregnancy outcomes Evidence from a case-control study[J]. Reprod Biomed Online,2014,29 (2) :216-221.
  • 7Orvieto R. Ovarian hyperstimulation syndrome-an optimal solution for an unresolved enignma[J]. J Ovarian Res,2013,6( 1 ) :77.
  • 8Porter RN, Smith W, Craft IL, et al. Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins [ J ]. Lancet, 1984,2 (8414) :1284-1285.
  • 9Fowler PA, Sorsa-Leslie T, Harris W, et al. Ovarian gonadotrophin surge-attenuating factor (GnSAF) :where are we after 20 years of re- search [ J ]. Reproduction,2003,126 ( 6 ) : 689 -699.
  • 10Ho CH, Chen SU, Peng FS, et al. Prospective comparison of short and long GnRH agonist protocols using recombinant gonadotrophins for IVF/ICSI treatments [ J ]. Reprod Biomed Online ,2008,16 (5) :632- 639.

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部